Author:
Hu Huiyu,Quintana Jeremy,Weissleder Ralph,Parangi Sareh,Miller Miles
Funder
National Institutes of Health
National Natural Science Foundation of China
China Scholarship Council
Reference243 articles.
1. Albumin as a versatile platform for drug half-life extension;Sleep;BBA,1830
2. M. Bern, J. Nilsen, M. Ferrarese, K. M. K. Sand, T. T. Gjølberg, H. E. Lode, R. J. Davidson, R. M. Camire, E. S. Bækkevold, S. Foss, A. Grevys, B. Dalhus, J. Wilson, L. S. Høydahl, G. J. Christianson, D. C. Roopenian, T. Schlothauer, T. E. Michaelsen, M. C. Moe, S. Lombardi, M. Pinotti, I. Sandlie, A. Branchini & J. T. Andersen. An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Sci Transl Med. 12(2020) eabb0580.
3. Advances in therapeutic fc engineering - modulation of igg-associated effector functions and serum half-life;Saxena;Front. Immunol.,2016
4. The major histocompatibility complex-related fc receptor for igg (fcrn) binds albumin and prolongs its lifespan;Chaudhury;J. Exp. Med.,2003
5. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites;Curry;Nat. Struct. Biol.,1998
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献